Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Lymic Lymph Node Metastasis In Intrahepatic Cholangiocarcinoma

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06381648Completed

Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)

NCT07454486Not Yet Recruiting

TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

Showing all 2 trials

Research Network

Common Treatments

  • Lymic Lymph Node Metastasis In Intrahepatic Cholangiocarcinoma1

Active Sponsors

  • Aarhus University Hospital1
  • City of Hope Medical Center1

Top Investigators

Related Conditions

  • Cholangiocarcinoma Intrahepatic2
  • Cholangiocarcinoma Resectable2
  • Cholangiocarcinoma2
  • Biliary Tract Cancer Btc1
  • Biliary Tract Cancer Cca1

Activity Timeline